Clinical and Laboratory Characteristics of Invasive Infections Due to Methicillin-Resistant Staphylococcus aureus Isolates Demonstrating a Vancomycin MIC of 2 Micrograms per Milliliter: Lack of Effect of Heteroresistant Vancomycin-Intermediate S. aureus Phenotype

被引：22

作者：

Satola, S. W. ^{[1
,2
]}

Lessa, F. C. ^{[3
]}

Ray, S. M. ^{[2
]}

Bulens, S. N. ^{[3
,4
]}

Lynfield, R. ^{[5
]}

Schaffner, W. ^{[6
]}

Dumyati, G. ^{[7
]}

Nadle, J. ^{[8
]}

Patel, J. B. ^{[3
]}

机构：

[1] Atlanta VA Med Ctr, Decatur, GA 30033 USA

[2] Emory Univ, Sch Med, Atlanta, GA USA

[3] Ctr Dis Control, Div Healthcare Qual Promot, Atlanta, GA 30333 USA

[4] Atlanta Res & Educ Fdn, Atlanta, GA USA

[5] Minnesota Dept Hlth, St Paul, MN USA

[6] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA

[7] Univ Rochester, Rochester, NY USA

[8] Calif Emerging Infect Program, Oakland, CA USA

来源：

JOURNAL OF CLINICAL MICROBIOLOGY | 2011年 / 49卷 / 04期

关键词：

UNITED-STATES; BACTEREMIA; MRSA; SUSCEPTIBILITY; FEATURES; OUTCOMES; PERIOD;

D O I：

10.1128/JCM.01719-10

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

We describe clinical and laboratory characteristics of invasive methicillin-resistant Staphylococcus aureus (MRSA) infections with vancomycin MICs of 2 mu g/ml and compare heteroresistant-intermediate S. aureus (hVISA) to non-hVISA. Health care-associated community-onset infections were the most common and resulted in frequent complications and relapses. hVISA-infected patients were more likely to have been hospitalized in the year prior to MRSA culture.

引用

页码：1583 / 1587

页数：5

共 25 条

[1] Detection and Characterization of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates in Canada: Results from the Canadian Nosocomial Infection Surveillance Program, 1995-2006
Adam, Heather J.
Louie, Lisa
Watt, Christine
Gravel, Denise
Bryce, Elizabeth
Loeb, Mark
Matlow, Anne
McGeer, Allison
Mulvey, Michael R.
Simor, Andrew E.
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (02) : 945 - 949
[2] [Anonymous], 2009, PERF STAND ANT DISK
[3] [Anonymous], 2009, METH DIL ANT SUSC TE
[4] Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus
Charles, PGP
Ward, PB
Johnson, PDR
Howden, BP
Grayson, ML
[J]. CLINICAL INFECTIOUS DISEASES, 2004, 38 (03) : 448 - 451
[5] Prospective Comparison of the Clinical Impacts of Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-Susceptible MRSA
Horne, K. C.
Howden, B. P.
Grabsch, E. A.
Graham, M.
Ward, P. B.
Xie, S.
Mayall, B. C.
Johnson, P. D. R.
Grayson, M. L.
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (08) : 3447 - 3452
[6] Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility
Howden, BP
Ward, PB
Charles, PGP
Korman, TM
Fuller, A
du Cros, P
Grabsch, EA
Roberts, SA
Robson, J
Read, K
Bak, N
Hurley, J
Johnson, PDR
Morris, AJ
Mayall, BC
Grayson, ML
[J]. CLINICAL INFECTIOUS DISEASES, 2004, 38 (04) : 521 - 528
[7] Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections
Hsu, Donald I.
Hidayat, Levita K.
Quist, Ryan
Hindler, Janet
Karlsson, Asa
Yusof, Anne
Wong-Beringer, Annie
[J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 32 (05) : 378 - 385
[8] Historical yearly usage of vancomycin
Kirst, HA
Thompson, DG
Nicas, TI
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (05) : 1303 - 1304
[9] Invasive methicillin-resistant Staphylococcus aureus infections in the United States
Klevens, R. Monina
Morrison, Melissa A.
Nadle, Joelle
Petit, Susan
Gershman, Ken
Ray, Susan
Harrison, Lee H.
Lynfield, Ruth
Dumyati, Ghinwa
Townes, John M.
Craig, Allen S.
Zell, Elizabeth R.
Fosheim, Gregory E.
McDougal, Linda K.
Carey, Roberta B.
Fridkin, Scott K.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (15): : 1763 - 1771
[10] Characterization of Methicillin-Resistant Staphylococcus aureus Isolates Collected in 2005 and 2006 from Patients with Invasive Disease: a Population-Based Analysis
Limbago, Brandi
Fosheim, Gregory E.
Schoonover, Valerie
Crane, Christina E.
Nadle, Joelle
Petit, Susan
Heltzel, David
Ray, Susan M.
Harrison, Lee H.
Lynfield, Ruth
Dumyati, Ghinwa
Townes, John M.
Schaffner, William
Mu, Yi
Fridkin, Scott K.
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2009, 47 (05) : 1344 - 1351

← 1 2 3 →